Extraneous 发表于 2025-3-21 18:45:55

书目名称Interferon: The Dawn of Recombinant Protein Drugs影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0471000<br><br>        <br><br>书目名称Interferon: The Dawn of Recombinant Protein Drugs读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0471000<br><br>        <br><br>

删除 发表于 2025-3-21 23:18:03

,The Clinical and Social Impact of Interferon-β: The First Approved Therapy in Multiple Sclerosis,. In this review I will examine the natural history of the disease in order for the reader to understand the difficulties associated with the care of patients with MS and in identifying new therapies for the disease. I will then discuss the impact of that approval and the current thoughts on treatment MS.

TRAWL 发表于 2025-3-22 02:03:47

http://reply.papertrans.cn/48/4710/471000/471000_3.png

GLUT 发表于 2025-3-22 07:42:24

0947-6075 er Andrewes (1896-1988). Let us go back more than 40 years. In 1956 Isaacs was in charge of the Wodd Influenza Centre. Andrewes was head of the division of bac­ teriology and virology, and deputy director of the National Institute for Medical Research in London. When researchers are faced with a see

虚构的东西 发表于 2025-3-22 12:16:44

,What Constitutes Therapeutic Success? The Interferons (1978–1998), exaggerated coverage in the media, high public expectations, widespread disappointment and loss of interest when the claims failed to materialize in large scale trials, researchers and administrators forced on the defensive. and finally there seems hardly any reason for continuation of research or for clinical application.

粗野 发表于 2025-3-22 14:46:00

http://reply.papertrans.cn/48/4710/471000/471000_6.png

抱负 发表于 2025-3-22 20:09:45

http://reply.papertrans.cn/48/4710/471000/471000_7.png

新手 发表于 2025-3-22 22:31:27

,Interferon-α: From Pass Interference to Cytokine Networking,f the functions of IFN become appreciated, with discovery of its roles in cell growth regulation and immune modulation. This early stage of interferon research (and which, indeed continues today at a more mechanistic, molecular level) can be thought of as the “pass interference” stage of interferon research.

urethritis 发表于 2025-3-23 04:38:53

Is There Life Without Interferon?,arly in evolutionary time, and so early that one can reasonably suppose they have a very fundamental role in multicellular organisms. Figure 1 is adapted from one in a 1985 paper by Weissmann and colleagues , and shows that the primitive IFN-α and IFN-β genes had already separated many million ye

果核 发表于 2025-3-23 06:55:33

http://reply.papertrans.cn/48/4710/471000/471000_10.png
页: [1] 2 3 4
查看完整版本: Titlebook: Interferon: The Dawn of Recombinant Protein Drugs; J. Lindenmann,W.-D. Schleuning Conference proceedings 1999 Springer-Verlag Berlin Heide